option delistings on September 25th

Option delistings effective September 25th include Phio Pharmaceuticals Corp (PHIO), ESG Orphans ETF (ORFN), Oblong (OBLG), New York City REIT (NYC), NuZee (NUZE), Moatable Inc (MTBL), Marker Therapeutics (MRKR), Mercurity Fintech Holdings (MFH), Mustang Bio (MBIO), Liminal BioSciences (LMNL), Lucira Health Inc (LHDXQ), Kiromic Biopharma Inc (KRBP), Imv Inc (IMVIQ), Hallmark Financial (HALL), Engine Media Holdings (GAME), iShares MSCI Emerging Markets Asia (EEMA), Dave Inc. (DAVE), ComSovereign Holding Corp (COMS), SPDR Kensho Clean Power ETF (CNRG), ChinaNet Online (CNET), Ci Financial Corporation (CIXXF), CHARAH SOLUTIONS INC. (CHRA), ContraFect (CFRX), Codiak Biosciences, Inc. (CDAKQ), Canon Inc (ADR) (CAJPY), Breakwave Sea Deacarbonization ETF (BSEA), Breeze Holdings Acquisition Corp (BREZ), AYTU BioPharma (AYTU), Avalo Therapeutics (AVTX), Athenex Inc (ATNXQ), Ascent Solar Tech. (ASTI), Altisource (ASPS), Aceragen Inc (ACGN), Reed‘S Inc (REED), Arcadia Biosciences (RKDA), Rubius Therapeutics Inc (RUBY), Statera Biopharma Inc (STAB), Steel Connect (STCN), SWVL Holdings Corp (SWVL), Tuesday Morning Corp (TUEMQ), Via Renewables (VIA), VYNE Therapeutics (VYNE), and Xinyuan Real Estate (XIN).